Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)—rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients

Peer Review reports

Original Submission
17 Mar 2022	Submitted	Original manuscript
19 May 2022	Reviewed	Reviewer Report - Kirsty Loudon
13 Jun 2022	Reviewed	Reviewer Report - Silke de Boer
4 Jul 2022	Author responded	Author comments - Matthew Tunbridge
Resubmission - Version 2
4 Jul 2022	Submitted	Manuscript version 2
18 Jul 2022	Author responded	Author comments - Matthew Tunbridge
Resubmission - Version 3
18 Jul 2022	Submitted	Manuscript version 3
Publishing
4 Aug 2022	Editorially accepted
15 Sep 2022	Article published	10.1186/s13063-022-06634-w

Back to article page